Peregrina Cheese Corporation Recalls All Products Manufactured In Its Plant Because Of Possible Health Risk

The US FDA has issued a press release to confirm that Peregrina Cheese Corporation of Brooklyn, New York, is recalling all products manufactured in its Brooklyn, NY plant from March 17, 2009 to the present date because they have the potential to be contaminated with Listeria monocytogenes.

This recall action is being conducted in accordance with the Consent Decree filed on July 20, 2009, which requires Peregrina Cheese Corporation to recall all products and codes produced in the Brooklyn plant from March 17, 2009 to the present. The recall action involves the following products produced since March 17, 2009:

• • Peregrina Cheese brand QUESO FRESCO Fresh Cheese, 14 Oz. (397 g) foil-wrapped package, Plant # 36-8431, UPC 8 17424 00024 6, all lot codes on the market produced since March 17, 2009.
  • Chipilo brand MEXICAN CHEESE QUESO FRESCO – Fresh Cheese, NET WT. 15 oz. (425g), Plant #36-8431, UPC 8 17424 00028 4, all lot codes on the market produced since March 17, 2009.
  • Peregrina Cheese brand QUESO HEBRA Queso Oaxaca, NET WT. 15 Oz. (425g), Plant #36-8431, UPC 8 17424 00026 0, all lot codes on the market produced since March 17, 2009.
  • Peregrina Cheese brand QUESO COTIJA MOLIDO, NET WT. 15 OZ. plastic bags, Plant # 36-1388, UPC 8 17424 00027 7, all lot codes on the market produced since March 17, 2009.
  • Peregrina Cheese brand Flan, NET WT 8 oz., Plant # 36-8431, UPC 8 17424 00026 0, all lot codes on the market produced since March 17, 2009.
  • Peregrina Cheese brand GELATIN, NET WT. 10 OZ., Plant # 36-8431, UPC 8 17424 00031 4, all lot codes on the market produced since March 17, 2009.
  • Peregrina Cheese brand CREMA MEXICANA Mexican Cream, Weight 16 Oz., Plant # 55-8991, UPC 8 17424 00030 7, all lot codes on the market produced since March 17, 2009.

The products were distributed to retail stores in New York and Pennsylvania.

No illnesses have been reported to date.

This recall action is being conducted with the knowledge of the FDA.